Solid State Pharma is a privately held solid state and crystallization engineering company that was founded in 2014. We are a recognized global leader in the delivery of crystallization engineering services, including screening and selection of polymorphs, co-crystals, salts, and crystallization process development and optimization.
We partner with pharmaceutical and natural product companies to add value to every process by understanding the solid state of their drug candidates, and developing processes that optimize physical properties, morphology and particle size distribution.
Our full suite of services includes comprehensive understanding of the solid state of APIs, and the regulatory requirements that are integral to effective development, innovation, and manufacturing. Solid State Pharma’s expertise helps to enhance the development of drug candidates and commercial products by enabling better quality products and a faster route to market.